A carregar...
Targeting Mediators of Smoking Persistence with Intranasal Insulin
Rapid-acting, non-irritating nasal treatment options for smoking cessation pharmacotherapy are lacking. The halt in development is due, in part, to difficulty in delivering compounds across the blood brain barrier. Recently, in both human and animal models, insulin was shown to be capable of being t...
Na minha lista:
| Publicado no: | Front Pharmacol |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Frontiers Media S.A.
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5649209/ https://ncbi.nlm.nih.gov/pubmed/29085297 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2017.00706 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|